Community Health Systems vs Encompass Health
CYH and EHC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CYH and EHC compare
Encompass Health is the larger company, worth 38 times as much as Community Health Systems ($13.0B against $338M).
On earnings, Community Health Systems is cheaper: it trades at 9.2× trailing earnings, against 21.4× for Encompass Health.
Encompass Health grew revenue faster over the last twelve months (9.5% versus −7.8% for Community Health Systems).
Encompass Health keeps more of each dollar of sales as profit, with a net margin of 10.0% compared with 0.31% at Community Health Systems.
Encompass Health pays a dividend yielding 0.59%; Community Health Systems does not pay one.
Encompass Health scores higher on the StockData Score (17 against 8 for Community Health Systems), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CYH | EHC |
|---|---|---|
| Size and price | ||
| Market cap | $338M | $13.0B |
| Share price | $2.40 | $131.49 |
| Change, 1 year | −43.0% | 4.1% |
| Change, 5 years | −83.3% | 102% |
| Beta (5Y) | 1.69 | 0.70 |
| Employees | 57K | 42K |
| StockData Score | ||
| Total score | 8 | 17 (better) |
| Valuation score | 3 (better) | 2 |
| Growth score | 2 | 4 (better) |
| Performance score | 2 | 5 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 9.2× (better) | 21.4× |
| P/S | 0.0× (better) | 2.1× |
| P/B | – | 5.0× |
| EV/EBITDA | 5.9× (better) | 10.9× |
| P/FCF | – | 31.4× |
| PEG | 0.08 (better) | 0.79 |
| FCF yield | −36.0% | 3.2% (better) |
| Fair value | – | $123.38 |
| Margin of safety | – | −6.6% |
| Growth | ||
| Revenue growth (TTM) | −7.8% | 9.5% (better) |
| Revenue growth, 5Y average | 1.2% | 10.7% (better) |
| Net income growth (TTM) | −89.1% | 18.8% (better) |
| EPS growth (TTM) | −89.3% | 20.2% (better) |
| EPS growth, 5Y average | −3.0% | 14.2% (better) |
| Profitability | ||
| Gross margin | 85.5% | – |
| Operating margin | 10.9% | – |
| Net margin | 0.31% | 10.0% (better) |
| FCF margin | −1.0% | 6.7% (better) |
| Return on equity | – | 25.5% |
| Return on invested capital | 7.5% | – |
| Financial health | ||
| Debt / equity | – | 1.01 |
| Net debt / EBITDA | 5.54 | 1.68 (better) |
| Current ratio | 1.48 (better) | 1.19 |
| Altman Z-score | 1.00 | 2.81 (better) |
| Piotroski F-score | 8 | 8 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.59% |
| Payout ratio | – | 12.1% |
| Years of dividend growth | – | 2 |
| Dividend growth, 5Y average | – | −8.5% |
| Buyback yield | – | 1.9% |
| Shareholder yield | 0.00% | 2.5% (better) |
| Ownership | ||
| Held by institutions | 82.7% | 97.0% |
| Held by insiders | 9.0% | 1.0% |
| Insider net buying, 12 months | −$118K (better) | −$47.8M |
| Short interest, % of float | 9.6% | 3.6% |
Go deeper
- CYH stock overview
- CYH income statement
- CYH valuation and score
- EHC stock overview
- EHC income statement
- EHC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.